Status:
COMPLETED
Different Doses of Vitamin A and Childhood Morbidity and Mortality
Lead Sponsor:
Bandim Health Project
Conditions:
Mortality
Morbidity
Eligibility:
All Genders
6-5 years
Phase:
PHASE4
Brief Summary
Vitamin A supplementation reduces all-cause mortality. It is therefore given with oral polio vaccine in national campaigns. However, it is not clear which dose is optimal. The two studies that have in...
Detailed Description
Vitamin A supplementation (VAS) to children above 6 months of age reduces all-cause mortality with 23 %1 to 30 % in low-income countries. WHO recommends VAS at vaccination contacts. The currently reco...
Eligibility Criteria
Inclusion
- Between 6 mo and 5 years old and thus eligible for OPV and vitamin A during national immunisation day
- \-
Exclusion
- Children with overt signs of vitamin A deficiency will not be enrolled in the study, but treated according to the recommendations. -
Key Trial Info
Start Date :
November 1 2002
Trial Type :
INTERVENTIONAL
End Date :
August 1 2003
Estimated Enrollment :
5400 Patients enrolled
Trial Details
Trial ID
NCT00168584
Start Date
November 1 2002
End Date
August 1 2003
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project, Apartado 861
Bissau, Guinea-Bissau